| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 2.31e-05 | 68 | 168 | 6 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.51e-05 | 69 | 168 | 6 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 3.18e-05 | 8 | 168 | 3 | GO:0140948 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.31e-05 | 44 | 168 | 5 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 6.72e-05 | 10 | 168 | 3 | GO:0140947 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.43e-04 | 229 | 168 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 1.57e-04 | 13 | 168 | 3 | GO:0046974 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.96e-04 | 188 | 168 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 2.36e-04 | 103 | 168 | 6 | GO:0008276 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 2.62e-04 | 105 | 168 | 6 | GO:0008170 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 3.30e-04 | 71 | 168 | 5 | GO:0042054 | |
| GeneOntologyMolecularFunction | myosin light chain kinase activity | 4.18e-04 | 4 | 168 | 2 | GO:0004687 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 5.50e-04 | 45 | 168 | 4 | GO:0043495 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 6.92e-04 | 5 | 168 | 2 | GO:0140444 | |
| GeneOntologyBiologicalProcess | cognition | SHANK1 RAG1 MAPT CHRM1 LILRB1 SLC1A4 RGS14 TTBK1 NRXN2 EGFR SETD5 KMT2A KCNAB1 PRKN DOP1B | 1.77e-06 | 423 | 166 | 15 | GO:0050890 |
| GeneOntologyCellularComponent | Golgi lumen | 2.86e-05 | 109 | 168 | 7 | GO:0005796 | |
| GeneOntologyCellularComponent | leading edge membrane | 5.23e-05 | 210 | 168 | 9 | GO:0031256 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 8.02e-05 | 11 | 168 | 3 | GO:0098966 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.37e-04 | 13 | 168 | 3 | GO:0099535 | |
| GeneOntologyCellularComponent | dendrite | SHANK1 PSD2 MAPT SYNE1 PPFIA2 PCLO BCAN CHRM1 SLC1A4 ARHGEF15 MYLK2 RGS14 PALM KCNAB1 COBL C4A C4B ARHGEF2 | 1.95e-04 | 858 | 168 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | cell projection membrane | LIMA1 PSD2 MAPT PIEZO1 DLC1 EGFR SYNJ2 SLC20A2 SYNE2 PALM ARHGEF2 IQCE | 1.98e-04 | 431 | 168 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | dendritic tree | SHANK1 PSD2 MAPT SYNE1 PPFIA2 PCLO BCAN CHRM1 SLC1A4 ARHGEF15 MYLK2 RGS14 PALM KCNAB1 COBL C4A C4B ARHGEF2 | 2.00e-04 | 860 | 168 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 3.19e-04 | 17 | 168 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | somatodendritic compartment | SHANK1 PSD2 MAPT SYNE1 PPFIA2 PCLO BCAN CHRM1 SLC1A4 ARHGEF15 MYLK2 RGS14 TTBK1 ACAN PALM KCNAB1 COBL PRKN C4A C4B ARHGEF2 SDC2 | 3.50e-04 | 1228 | 168 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | tenascin complex | 3.81e-04 | 4 | 168 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | AKAP6 SYNE1 PCLO ANGEL1 IRAG1 SRCAP PACS1 TTBK1 IGF2R SBF1 EGFR SYNJ2 TRAPPC12 COBL PRKN PATJ MTDH WDR44 | 5.38e-04 | 934 | 168 | 18 | GO:0048471 |
| GeneOntologyCellularComponent | cell leading edge | LIMA1 PSD2 MAPT PIEZO1 PTPN13 DLC1 EGFR SYNJ2 SYNE2 PALM COBL ARHGEF2 | 7.47e-04 | 500 | 168 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.07e-03 | 96 | 168 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | lysosomal lumen | 1.17e-03 | 98 | 168 | 5 | GO:0043202 | |
| GeneOntologyCellularComponent | ruffle | 1.41e-03 | 206 | 168 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.74e-03 | 8 | 168 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | ruffle membrane | 1.81e-03 | 108 | 168 | 5 | GO:0032587 | |
| HumanPheno | Long eyelashes | HECTD4 SRCAP PACS1 FRMD4A ARID1B EGFR KMT2A SMARCC2 ARHGEF2 KDM6A | 4.20e-06 | 129 | 65 | 10 | HP:0000527 |
| Domain | PDZ | SHANK1 PCLO FRMPD1 PTPN13 GORASP1 AHNAK PATJ SDCBP2 ARHGAP21 | 6.86e-06 | 151 | 162 | 9 | PS50106 |
| Domain | PDZ | SHANK1 PCLO FRMPD1 PTPN13 GORASP1 AHNAK PATJ SDCBP2 ARHGAP21 | 7.24e-06 | 152 | 162 | 9 | IPR001478 |
| Domain | - | 5.00e-05 | 150 | 162 | 8 | 2.30.42.10 | |
| Domain | Dopey_N | 7.48e-05 | 2 | 162 | 2 | PF04118 | |
| Domain | Dopey_N | 7.48e-05 | 2 | 162 | 2 | IPR007249 | |
| Domain | PDZ | 2.32e-04 | 141 | 162 | 7 | PF00595 | |
| Domain | PDZ | 3.12e-04 | 148 | 162 | 7 | SM00228 | |
| Domain | KASH | 4.44e-04 | 4 | 162 | 2 | IPR012315 | |
| Domain | KASH | 4.44e-04 | 4 | 162 | 2 | PS51049 | |
| Domain | KASH | 4.44e-04 | 4 | 162 | 2 | SM01249 | |
| Domain | KASH | 4.44e-04 | 4 | 162 | 2 | PF10541 | |
| Domain | DUF3338 | 4.44e-04 | 4 | 162 | 2 | PF11819 | |
| Domain | DUF3338 | 4.44e-04 | 4 | 162 | 2 | IPR021774 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.06e-05 | 76 | 112 | 6 | M27219 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.40e-05 | 47 | 112 | 5 | MM14925 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 7.69e-05 | 29 | 112 | 4 | M48076 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.42e-04 | 143 | 112 | 7 | M27275 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.17e-04 | 69 | 112 | 5 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.32e-04 | 70 | 112 | 5 | M41806 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 3.05e-04 | 41 | 112 | 4 | M27257 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | LIMA1 IRS4 ACACA MAPT IQSEC2 ANKRD26 LAMC1 SIK1 EDC4 RAB11FIP1 ARHGEF17 MYLK2 MEX3C CEP350 JUP PTPN13 DLC1 MYLK3 SBF1 FAM171A2 SYNJ2 STARD9 AHNAK SYNE2 KMT2A COBL ARHGEF2 PATJ ARHGAP21 DOP1A DOP1B | 2.78e-18 | 861 | 169 | 31 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ACACA SZT2 PIEZO1 INTS1 HECTD4 ANKLE1 HUWE1 EDC4 WRAP53 SRCAP C2CD2L PWWP2B IGF2R WIZ SBF1 TRAPPC12 SETD5 TRIM28 AHNAK MCM3AP PALM COBL HMGXB3 ARHGEF2 AGRN ARHGAP21 CRAMP1 IQCE | 8.34e-13 | 1105 | 169 | 28 | 35748872 |
| Pubmed | LIMA1 IRS4 GALK1 ACACA DIDO1 SPECC1L HUWE1 EDC4 SRCAP JUP ARID1B PTPN13 WIZ TRIM28 AHNAK KMT2A PATJ USP15 KDM6A WDR44 | 3.42e-12 | 549 | 169 | 20 | 38280479 | |
| Pubmed | LIMA1 PPAN IRS4 RARRES1 PCDHGA4 SYNE1 PPFIA2 PCLO ANKRD26 SIK1 ATP10B SRCAP MYLK2 RGS14 SETD5 STARD9 AHNAK SYNE2 PALM KMT2A SMARCC2 CFAP74 ARHGEF2 MAPK6 ZBTB11 PCDHGA8 MTDH ARHGAP21 DOP1A | 8.21e-11 | 1442 | 169 | 29 | 35575683 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LIMA1 PPAN ACACA MAPT DIDO1 PAGR1 HUWE1 GPATCH8 TSSC4 WRAP53 PACS1 PWWP2B EGFR TRIM28 KMT2A SMARCC2 ARHGEF2 KDM6A UNC5D DYNC1LI2 WDR44 | 2.25e-10 | 774 | 169 | 21 | 15302935 |
| Pubmed | SHANK1 LIMA1 MAPT TNC SYNE1 PPFIA2 PCLO LRRC49 IQSEC2 BCAN SPECC1L EDC4 ARHGEF17 SLC1A4 PACS1 JUP SBF1 NRXN2 TRIM28 PALM KMT2A SMARCC2 C4A C4B ARHGEF2 MTDH ARHGAP21 | 1.59e-09 | 1431 | 169 | 27 | 37142655 | |
| Pubmed | ZFYVE16 SYNE1 FRMPD1 GON4L GPATCH8 ARHGEF17 C2CD2L SETDB1 SETD5 STARD9 MCM3AP COBL USP15 ARHGAP21 DOP1B | 1.68e-09 | 407 | 169 | 15 | 12693553 | |
| Pubmed | SHANK1 LIMA1 TCAF1 SYNE1 IQSEC2 HECTD4 DIDO1 SPECC1L HUWE1 EDC4 IGF2R WIZ SBF1 FAM171A2 TRIM28 SYNE2 DCHS1 KCNAB1 SMARCC2 ARHGEF2 AGRN ARHGAP21 | 1.99e-09 | 963 | 169 | 22 | 28671696 | |
| Pubmed | AKAP6 ZFYVE16 DIDO1 SPECC1L HUWE1 SRCAP ARHGEF17 SYNJ2 PCDHGA8 | 2.26e-09 | 104 | 169 | 9 | 9205841 | |
| Pubmed | IRS4 ACACA ZFYVE16 LRRC49 MECOM LAMC1 HUWE1 RBBP8NL SETDB1 JUP PTPN13 WIZ AHNAK ZBTB11 ARHGAP21 | 2.42e-09 | 418 | 169 | 15 | 34709266 | |
| Pubmed | IRS4 ACACA LRRC49 ANKRD26 RAB11FIP1 PACS1 JUP PTPN13 IGF2R SBF1 FAM171A2 EGFR PALM COBL ARHGAP21 | 2.66e-09 | 421 | 169 | 15 | 36976175 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | PPAN IRS4 ACACA HECTD4 HUWE1 GPATCH8 SRCAP SETDB1 ARID1B SBF1 TRIM28 SMARCC2 ARHGEF2 ZBTB11 USP15 | 4.82e-09 | 440 | 169 | 15 | 34244565 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 GNL3L ACACA MAPT PPFIA2 FRMPD1 HECTD4 HUWE1 RBBP8NL BRWD3 PACS1 TSC22D1 PTPN13 PWWP2B EGFR SYNJ2 SETD5 SETBP1 COBL PRKN MAPK6 PATJ USP15 KDM6A CRAMP1 DOP1A | 1.61e-08 | 1489 | 169 | 26 | 28611215 |
| Pubmed | AKAP6 TCAF1 FRMPD1 ANGEL1 DIDO1 PABPN1L HUWE1 GPATCH8 SRCAP PACS1 JUP ARID1B PTPN13 IGF2R SETD5 HMGXB3 PATJ SUCO AGRN MTDH ARHGAP21 DYNC1LI2 | 1.68e-08 | 1084 | 169 | 22 | 11544199 | |
| Pubmed | SHANK1 SYNE1 MUC12 SPECC1L CEP350 SETDB1 TSC22D1 JUP SYNJ2 TRIM28 MCM3AP COBL C4A MAPK6 WDR44 | 1.81e-08 | 486 | 169 | 15 | 20936779 | |
| Pubmed | GNL3L ANGEL1 GON4L DIDO1 ZXDB PACS1 SBF1 GORASP1 RECQL4 KMT2A C4A C4B ARHGEF2 PATJ ZBTB11 AGRN ARHGAP21 | 2.22e-08 | 650 | 169 | 17 | 38777146 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MXRA5 ACACA PPFIA2 PCLO IQSEC2 INTS1 MUC19 HUWE1 ARHGEF17 ZBTB44 JUP WIZ AHNAK MCM3AP RECQL4 ZBTB11 IQCE DOP1B | 2.33e-08 | 736 | 169 | 18 | 29676528 |
| Pubmed | 4.46e-08 | 146 | 169 | 9 | 27068509 | ||
| Pubmed | ACACA ANGEL1 ANKRD26 MUC16 SPECC1L HUWE1 PPM1G CEP350 PTPN13 IGF2R WIZ FAM171A2 EGFR AHNAK MTDH ARHGAP21 DYNC1LI2 IQCE | 5.26e-08 | 777 | 169 | 18 | 35844135 | |
| Pubmed | PPAN GNL3L SYNE1 CDKN2AIP PIEZO1 HMGXB4 INTS1 GON4L DIDO1 SPECC1L GPATCH8 EDC4 RAB11FIP1 WRAP53 MYLK2 C2CD2L PTPN13 WIZ SBF1 SETD5 KMT2A ARHGEF2 PATJ ZBTB11 AGRN | 7.37e-08 | 1497 | 169 | 25 | 31527615 | |
| Pubmed | Enhanced transcription of complement and coagulation genes in the absence of adaptive immunity. | 1.13e-07 | 3 | 169 | 3 | 19200601 | |
| Pubmed | Innate response to self-antigen significantly exacerbates burn wound depth. | 1.13e-07 | 3 | 169 | 3 | 17360462 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | GNL3L ANKRD26 RAB11FIP1 SLC1A4 PACS1 FRMD4A IGF2R FAM171A2 EGFR SLC20A2 PALM COBL ATP13A3 PATJ ARHGAP21 | 1.40e-07 | 569 | 169 | 15 | 30639242 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NIBAN1 LIMA1 PPAN IRS4 SYNE1 INTS1 LAMC1 SPECC1L HUWE1 EDC4 SRCAP CEP350 JUP IGF2R TRIM28 AHNAK SYNE2 SMARCC2 ARHGEF2 MTDH | 1.46e-07 | 1024 | 169 | 20 | 24711643 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | LIMA1 IRS4 GNL3L ACACA ZFYVE16 CDKN2AIP ANKRD26 DIDO1 EDC4 SRCAP JUP PTPN13 WIZ TRIM28 AHNAK KMT2A MTDH ARHGAP21 WDR44 | 1.65e-07 | 934 | 169 | 19 | 33916271 |
| Pubmed | IRS4 ZFYVE16 CDKN2AIP HUWE1 RAB11FIP1 PPM1G CEP350 PACS1 ARID1B PTPN13 IGF2R WIZ SBF1 FAM171A2 EGFR AHNAK SYNE2 PALM ARHGEF2 KDM6A | 2.15e-07 | 1049 | 169 | 20 | 27880917 | |
| Pubmed | AKAP6 SZT2 PIEZO1 HECTD4 DIDO1 ARID1B SBF1 NRXN2 SYNJ2 SETBP1 PALM HMGXB3 CRAMP1 IQCE | 3.56e-07 | 529 | 169 | 14 | 14621295 | |
| Pubmed | Intestinal reperfusion injury is mediated by IgM and complement. | 4.49e-07 | 4 | 169 | 3 | 10066708 | |
| Pubmed | The spatiotemporal expression pattern of Syndecans in murine embryonic teeth. | 6.34e-07 | 34 | 169 | 5 | 32220631 | |
| Pubmed | GNL3L ZFYVE16 MECOM HUWE1 GPATCH8 C2CD2L CEP350 SETDB1 ARID1B IGF2R SYNJ2 TRAPPC12 ARHGEF2 PATJ USP15 DYNC1LI2 | 6.61e-07 | 733 | 169 | 16 | 34672954 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 6.62e-07 | 101 | 169 | 7 | 20551380 | |
| Pubmed | IRS4 ACACA INTS1 DIDO1 HUWE1 EDC4 PPM1G IGF2R SBF1 AHNAK MCM3AP SYNE2 KMT2A SMARCC2 ZBTB11 | 7.99e-07 | 653 | 169 | 15 | 22586326 | |
| Pubmed | 8.62e-07 | 105 | 169 | 7 | 9628581 | ||
| Pubmed | NIBAN1 SCHIP1 ZFYVE16 SYNE1 MUC19 RAB11FIP1 IGF2R EGFR MTDH DYNC1LI2 WDR44 | 9.42e-07 | 339 | 169 | 11 | 37232246 | |
| Pubmed | LIMA1 CDKN2AIP INTS1 DIDO1 EDC4 EGFR TRIM28 AHNAK SMARCC2 COBL ARHGEF2 | 9.70e-07 | 340 | 169 | 11 | 24332808 | |
| Pubmed | Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. | 1.12e-06 | 5 | 169 | 3 | 22939622 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SYNE1 HMGXB4 INTS1 HECTD4 DIDO1 GPATCH8 SRCAP ARID1B PTPN13 WIZ SBF1 NRXN2 TRIM28 SMARCC2 ARHGEF2 AGRN TNXB MTDH DYNC1LI2 | 1.50e-06 | 1082 | 169 | 19 | 38697112 |
| Pubmed | 1.72e-06 | 225 | 169 | 9 | 12168954 | ||
| Pubmed | AAMP C14orf93 CDKN2AIP PIEZO1 KIAA0586 GON4L MECOM LAMC1 DIDO1 SPECC1L GPATCH8 BNC1 ZBTB44 TSC22D1 RECQL4 PALM ARHGEF2 C1orf94 AGRN UNC5D | 2.08e-06 | 1215 | 169 | 20 | 15146197 | |
| Pubmed | Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region. | 2.23e-06 | 6 | 169 | 3 | 11773012 | |
| Pubmed | GALK1 GNL3L MAPT HMGXB4 ANGEL1 MECOM RAB11FIP1 SRCAP BRWD3 C2CD2L SETDB1 ARID1B PWWP2B WIZ SETD5 TRIM28 MCM3AP SMARCC2 UNC5D | 2.35e-06 | 1116 | 169 | 19 | 31753913 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | GALK1 SYNE1 ANGEL1 LAMC1 RAB11FIP1 SLC1A4 PTPN13 IGF2R EGFR SYNJ2 PALM COBL ATP13A3 AGRN ARHGAP21 | 2.61e-06 | 719 | 169 | 15 | 35337019 |
| Pubmed | SHANK1 ACACA MAPT PPFIA2 PCLO IQSEC2 HUWE1 EDC4 SLC1A4 PPM1G C2CD2L FRMD4A FAM171A2 TRIM28 PALM KCNAB1 SMARCC2 USP15 MTDH | 3.15e-06 | 1139 | 169 | 19 | 36417873 | |
| Pubmed | AAMP MXRA5 ABCA4 TNC MUC16 LAMC1 CEP350 ARID1B TRAPPC12 SYNE2 PHACTR3 SMARCC2 ARHGEF2 KDM6A | 3.20e-06 | 638 | 169 | 14 | 31182584 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | TCAF1 IRS4 PCLO LAMC1 HUWE1 GPATCH8 ARHGEF17 CEP350 SBF1 TRIM28 KMT2A ARHGEF2 MAPK6 AGRN | 3.26e-06 | 639 | 169 | 14 | 23443559 |
| Pubmed | GNL3L CENPT ZFYVE16 ANKRD26 GON4L MECOM HUWE1 EDC4 SRCAP PPM1G CEP350 AHNAK KMT2A USP15 | 3.63e-06 | 645 | 169 | 14 | 25281560 | |
| Pubmed | 3.68e-06 | 22 | 169 | 4 | 27527664 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 22037602 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | TCAF1 INTS1 GON4L DIDO1 EDC4 SRCAP PPM1G WIZ AHNAK KMT2A SMARCC2 | 4.01e-06 | 394 | 169 | 11 | 27248496 |
| Pubmed | 4.39e-06 | 87 | 169 | 6 | 12465718 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | GALK1 HMGXB4 DIDO1 HUWE1 GPATCH8 EDC4 SRCAP SETDB1 TRIM28 AHNAK | 5.74e-06 | 332 | 169 | 10 | 32786267 |
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 6.20e-06 | 8 | 169 | 3 | 10072631 | |
| Pubmed | LIMA1 PPAN IRS4 LRRC49 HMGXB4 GON4L MECOM DIDO1 PAGR1 GPATCH8 EDC4 SRCAP PPM1G SETDB1 JUP ARID1B WIZ SYNE2 KMT2A SMARCC2 KDM6A | 6.60e-06 | 1429 | 169 | 21 | 35140242 | |
| Pubmed | 6.66e-06 | 54 | 169 | 5 | 36237976 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 8.26e-06 | 97 | 169 | 6 | 27559042 | |
| Pubmed | MAPT TNC PPFIA2 PCLO BCAN SLC1A4 C2CD2L PALM ARHGEF2 DYNC1LI2 | 8.44e-06 | 347 | 169 | 10 | 17114649 | |
| Pubmed | 8.54e-06 | 274 | 169 | 9 | 34244482 | ||
| Pubmed | 9.39e-06 | 210 | 169 | 8 | 16565220 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | A1BG AAMP HMGXB4 LAMC1 TSSC4 PPM1G SETDB1 TSC22D1 WIZ SBF1 NRXN2 GORASP1 MCM3AP SYNE2 PHACTR3 PRKN HMGXB3 MAPK6 | 1.01e-05 | 1124 | 169 | 18 | 21900206 |
| Pubmed | 1.10e-05 | 102 | 169 | 6 | 11214970 | ||
| Pubmed | 1.17e-05 | 285 | 169 | 9 | 34369648 | ||
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 12665591 | ||
| Pubmed | 1.54e-05 | 64 | 169 | 5 | 22261194 | ||
| Pubmed | AKAP6 SHANK1 FAM86B1 SYNE1 IQSEC2 HECTD4 HUWE1 WRAP53 BRWD3 CEP350 ZBTB44 SETDB1 PTPN13 WIZ CD74 ZBTB11 KDM6A ARHGAP21 DOP1B | 1.72e-05 | 1285 | 169 | 19 | 35914814 | |
| Pubmed | Organizations and gene duplications of the human and mouse MHC complement gene clusters. | 1.81e-05 | 11 | 169 | 3 | 10686478 | |
| Pubmed | 1.93e-05 | 67 | 169 | 5 | 29254152 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 19062096 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16299103 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.35e-05 | 2 | 169 | 2 | 17645767 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12207352 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 9321695 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 36878305 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.35e-05 | 2 | 169 | 2 | 27758680 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11792814 | ||
| Pubmed | De novo DNA methylation of endogenous retroviruses is shaped by KRAB-ZFPs/KAP1 and ESET. | 2.35e-05 | 2 | 169 | 2 | 23293284 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.35e-05 | 2 | 169 | 2 | 3037333 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11726230 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 4216347 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28263981 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 2.35e-05 | 2 | 169 | 2 | 8428773 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 32017279 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 2.35e-05 | 2 | 169 | 2 | 21345967 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 2302180 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22151770 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 29080553 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 2.35e-05 | 2 | 169 | 2 | 25339671 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17728371 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 6149580 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 6149581 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 3542363 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 2387317 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 7365238 | ||
| Pubmed | Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells. | 2.35e-05 | 2 | 169 | 2 | 31617054 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17971360 | ||
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 2.35e-05 | 2 | 169 | 2 | 17971229 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17202312 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 35898513 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 7524681 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28873507 | ||
| Interaction | YWHAH interactions | LIMA1 IRS4 MAPT IQSEC2 HECTD4 ANKRD26 SIK1 SPECC1L HUWE1 EDC4 RAB11FIP1 ARHGEF17 MEX3C CEP350 PACS1 FRMD4A JUP PTPN13 SBF1 FAM171A2 SYNJ2 STARD9 AHNAK SYNE2 RECQL4 KMT2A COBL PRKN ARHGEF2 PATJ SUCO ARHGAP21 DOP1A DOP1B | 2.25e-11 | 1102 | 167 | 34 | int:YWHAH |
| Interaction | YWHAG interactions | LIMA1 IRS4 MAPT IQSEC2 HECTD4 ANKRD26 SIK1 SPECC1L HUWE1 EDC4 RAB11FIP1 ARHGEF17 MYLK2 C2CD2L CEP350 PACS1 FRMD4A JUP PTPN13 TTBK1 DLC1 SBF1 FAM171A2 SYNJ2 STARD9 SYNE2 RECQL4 KMT2A COBL PRKN ARHGEF2 PATJ SUCO ARHGAP21 DOP1A | 1.49e-10 | 1248 | 167 | 35 | int:YWHAG |
| Interaction | TNIK interactions | SHANK1 TRIM2 MAPT SYNE1 IQSEC2 HUWE1 EDC4 WIZ EGFR TRIM28 SYNE2 DCHS1 SMARCC2 ARHGEF2 AGRN ARHGAP21 DYNC1LI2 | 1.98e-08 | 381 | 167 | 17 | int:TNIK |
| Interaction | STX7 interactions | NIBAN1 IRS4 ZFYVE16 MAPT ANKRD26 RAB11FIP1 C2CD2L RGS14 JUP IGF2R FAM171A2 EGFR SLC20A2 GORASP1 SYNE2 PALM PACC1 ATP13A3 MAPK6 MTDH ARHGAP21 WDR44 | 2.88e-08 | 659 | 167 | 22 | int:STX7 |
| Interaction | RAC3 interactions | IRS4 ZFYVE16 MAPT ANKRD26 RAB11FIP1 JUP PTPN13 IGF2R SBF1 FAM171A2 EGFR SYNJ2 SLC20A2 PALM PRKN ATP13A3 MTDH SDC2 ARHGAP21 DOP1A | 2.18e-07 | 619 | 167 | 20 | int:RAC3 |
| Interaction | SFN interactions | LIMA1 IRS4 MAPT ANKRD26 EDC4 RAB11FIP1 ARHGEF17 CEP350 PTPN13 FAM171A2 EGFR SYNJ2 TRIM28 RECQL4 KMT2A COBL PRKN ARHGEF2 MAPK6 ARHGAP21 DOP1A | 2.99e-07 | 692 | 167 | 21 | int:SFN |
| Interaction | YWHAQ interactions | LIMA1 IRS4 ACACA MAPT IQSEC2 HECTD4 ANKRD26 SIK1 SPECC1L RAB11FIP1 MYLK2 CEP350 PTPN13 SBF1 FAM171A2 EGFR SYNJ2 TRIM28 STARD9 RECQL4 KMT2A CD74 PRKN ARHGEF2 SUCO ARHGAP21 DOP1A | 5.20e-07 | 1118 | 167 | 27 | int:YWHAQ |
| Interaction | NUP43 interactions | GNL3L CENPT ACACA SZT2 CDKN2AIP MUC19 GON4L GPATCH8 SRCAP ARID1B EGFR TRAPPC12 MCM3AP SYNE2 RECQL4 KMT2A PRKN FAM199X ZBTB11 | 1.12e-06 | 625 | 167 | 19 | int:NUP43 |
| Interaction | CDC42 interactions | LIMA1 IRS4 ACACA MAPT SYNE1 ANKRD26 MUC12 HUWE1 EDC4 RAB11FIP1 ARHGEF15 RGS14 JUP PTPN13 IGF2R SBF1 EGFR TRIM28 SLC20A2 AHNAK MCM3AP SYNE2 RECQL4 COBL PRKN ATP13A3 MAPK6 MTDH ARHGAP21 | 1.35e-06 | 1323 | 167 | 29 | int:CDC42 |
| Interaction | RHOB interactions | IRS4 GNL3L ZFYVE16 IQSEC2 ANKRD26 RAB11FIP1 C2CD2L JUP PTPN13 IGF2R SBF1 FAM171A2 EGFR SLC20A2 PALM COBL ATP13A3 ARHGEF2 PATJ SDC2 ARHGAP21 WDR44 | 1.80e-06 | 840 | 167 | 22 | int:RHOB |
| Interaction | PPP1CB interactions | LIMA1 GNL3L ZFYVE16 MAPT INTS1 SPECC1L PACS1 RGS14 EGFR TRIM28 PHACTR3 PPP1R2C COBL PRKN ARHGAP21 WDR44 | 1.91e-06 | 469 | 167 | 16 | int:PPP1CB |
| Interaction | RAC1 interactions | LIMA1 IRS4 ZFYVE16 MAPT IQSEC2 ANKRD26 HUWE1 RAB11FIP1 PACS1 JUP PTPN13 IGF2R SBF1 FAM171A2 EGFR SYNJ2 SLC20A2 MCM3AP PALM COBL PRKN ATP13A3 ARHGEF2 SDC2 ARHGAP21 | 2.33e-06 | 1063 | 167 | 25 | int:RAC1 |
| Interaction | WWTR1 interactions | LIMA1 IRS4 GALK1 DIDO1 SPECC1L EDC4 SRCAP ARID1B PTPN13 WIZ KMT2A PATJ USP15 KDM6A WDR44 | 2.46e-06 | 422 | 167 | 15 | int:WWTR1 |
| Interaction | AP2M1 interactions | LIMA1 ACACA MAPT MECOM SPECC1L HUWE1 TSSC4 MEX3C EGFR TRIM28 PRKN FAM199X USP15 MTDH MAGEC2 | 3.10e-06 | 430 | 167 | 15 | int:AP2M1 |
| Interaction | TOP3B interactions | LIMA1 ACACA SZT2 PIEZO1 INTS1 HECTD4 ANKLE1 HUWE1 EDC4 WRAP53 SRCAP C2CD2L PWWP2B IGF2R WIZ SBF1 TRAPPC12 SETD5 TRIM28 AHNAK MCM3AP PALM COBL PRKN HMGXB3 ARHGEF2 AGRN ARHGAP21 CRAMP1 IQCE | 3.70e-06 | 1470 | 167 | 30 | int:TOP3B |
| Interaction | YWHAZ interactions | BDP1 LIMA1 IRS4 MAPT PPFIA2 IQSEC2 HECTD4 ANKRD26 LAMC1 SIK1 HUWE1 RAB11FIP1 MYLK2 PACS1 JUP PTPN13 SBF1 FAM171A2 EGFR STARD9 SYNE2 RECQL4 KMT2A CD74 PRKN ARHGEF2 SUCO ARHGAP21 | 3.91e-06 | 1319 | 167 | 28 | int:YWHAZ |
| Interaction | H3-3A interactions | CENPT MAPT HMGXB4 INTS1 DIDO1 GPATCH8 TSSC4 SRCAP BRWD3 MYLK2 PPM1G WIZ EGFR TRIM28 PHACTR3 KMT2A SMARCC2 PRKN ZBTB11 USP15 | 4.14e-06 | 749 | 167 | 20 | int:H3-3A |
| Interaction | RNF123 interactions | A1BG MXRA5 ACACA PPFIA2 PCLO IQSEC2 INTS1 MUC19 HUWE1 ARHGEF17 ZBTB44 JUP WIZ AHNAK MCM3AP RECQL4 PRKN ZBTB11 MTDH IQCE DOP1B | 4.82e-06 | 824 | 167 | 21 | int:RNF123 |
| Interaction | ARHGEF7 interactions | 5.34e-06 | 153 | 167 | 9 | int:ARHGEF7 | |
| Interaction | RAB35 interactions | IRS4 ANKRD26 RAB11FIP1 C2CD2L RGS14 JUP PTPN13 IGF2R SBF1 FAM171A2 EGFR SLC20A2 SYNE2 PALM PRKN ATP13A3 ARHGAP21 | 5.86e-06 | 573 | 167 | 17 | int:RAB35 |
| Interaction | CCDC8 interactions | NIBAN1 LIMA1 IRS4 IQSEC2 INTS1 LAMC1 SPECC1L HUWE1 CEP350 JUP IGF2R TRIM28 AHNAK RECQL4 SMARCC2 PRKN ARHGEF2 MTDH | 8.97e-06 | 656 | 167 | 18 | int:CCDC8 |
| Interaction | DIRAS3 interactions | IRS4 LRRC49 ANKRD26 HUWE1 PPM1G JUP PTPN13 IGF2R EGFR PALM ARHGAP21 | 1.23e-05 | 262 | 167 | 11 | int:DIRAS3 |
| Interaction | EIF3C interactions | BDP1 PCLO ANGEL1 MECOM PPM1G EGFR TRIM28 RECQL4 CD74 PRKN MAPK6 | 1.27e-05 | 263 | 167 | 11 | int:EIF3C |
| Interaction | PSMC5 interactions | SCHIP1 ACACA MAPT MECOM LAMC1 HUWE1 JUP EGFR TRIM28 RECQL4 KMT2A SMARCC2 PRKN MAPK6 USP15 | 1.28e-05 | 484 | 167 | 15 | int:PSMC5 |
| Interaction | KCNH1 interactions | 1.60e-05 | 19 | 167 | 4 | int:KCNH1 | |
| Interaction | H3C1 interactions | RAG1 CENPT MAPT SYNE1 HMGXB4 INTS1 MECOM DIDO1 PABPN1L TSSC4 SRCAP MYLK2 PPM1G SETDB1 WIZ EGFR TRIM28 AHNAK KMT2A SMARCC2 KDM6A | 1.86e-05 | 901 | 167 | 21 | int:H3C1 |
| Interaction | ACTR1A interactions | MAPT MECOM HUWE1 EGFR TRIM28 RECQL4 SMARCC2 PRKN INAVA USP15 DYNC1LI2 | 1.86e-05 | 274 | 167 | 11 | int:ACTR1A |
| Interaction | WDR26 interactions | 1.89e-05 | 179 | 167 | 9 | int:WDR26 | |
| Interaction | RHOQ interactions | IRS4 ZFYVE16 ANKRD26 RAB11FIP1 JUP PTPN13 IGF2R SBF1 FAM171A2 EGFR SLC20A2 PALM ATP13A3 ARHGAP21 | 1.98e-05 | 442 | 167 | 14 | int:RHOQ |
| Interaction | DNAH8 interactions | 1.99e-05 | 20 | 167 | 4 | int:DNAH8 | |
| Interaction | AFDN interactions | LIMA1 MAPT ANKRD26 JUP PTPN13 FAM171A2 NRXN2 EGFR KMT2A PRKN PATJ ARHGAP21 | 2.26e-05 | 333 | 167 | 12 | int:AFDN |
| Interaction | ZFPL1 interactions | IRS4 ANKRD26 RAB11FIP1 C2CD2L JUP PTPN13 IGF2R FAM171A2 EGFR SLC20A2 PALM PRKN ATP13A3 ARHGAP21 | 2.29e-05 | 448 | 167 | 14 | int:ZFPL1 |
| Interaction | PSMC2 interactions | LIMA1 ACACA MAPT MECOM HUWE1 MYLK2 EGFR TRIM28 RECQL4 CD74 PRKN MAPK6 USP15 | 2.52e-05 | 393 | 167 | 13 | int:PSMC2 |
| Interaction | PSMC4 interactions | LIMA1 ACACA MAPT MECOM HUWE1 PPM1G EGFR TRIM28 RECQL4 PRKN MAPK6 USP15 | 3.11e-05 | 344 | 167 | 12 | int:PSMC4 |
| Interaction | YWHAB interactions | LIMA1 IRS4 MAPT IQSEC2 HECTD4 ANKRD26 SIK1 RAB11FIP1 ARHGEF17 CEP350 PTPN13 FAM171A2 EGFR SYNJ2 STARD9 RECQL4 KMT2A CD74 PRKN ARHGEF2 SUCO ARHGAP21 | 3.45e-05 | 1014 | 167 | 22 | int:YWHAB |
| Interaction | MYCBP2 interactions | LIMA1 SPECC1L HUWE1 MEX3C EGFR TRIM28 SYNE2 SMARCC2 ARHGEF2 MAPK6 USP15 ARHGAP21 | 4.22e-05 | 355 | 167 | 12 | int:MYCBP2 |
| Interaction | MAP3K12 interactions | 4.25e-05 | 24 | 167 | 4 | int:MAP3K12 | |
| Interaction | FLOT1 interactions | LIMA1 IRS4 PCLO LRRC49 ANKRD26 RAB11FIP1 JUP PTPN13 FAM171A2 EGFR PALM PRKN PATJ ARHGAP21 | 4.34e-05 | 475 | 167 | 14 | int:FLOT1 |
| Interaction | HDAC1 interactions | IRS4 ACACA ZFYVE16 LRRC49 GON4L MECOM SETDB1 JUP PTPN13 PWWP2B WIZ EGFR TRIM28 AHNAK SYNE2 RECQL4 KMT2A SMARCC2 PRKN ZBTB11 USP15 ARHGAP21 FOXJ1 | 4.48e-05 | 1108 | 167 | 23 | int:HDAC1 |
| Interaction | ANK3 interactions | 4.70e-05 | 201 | 167 | 9 | int:ANK3 | |
| Interaction | ANXA2 interactions | LIMA1 MAPT TNC HUWE1 RGS14 JUP EGFR AHNAK RECQL4 PRKN MTDH ARHGAP21 DYNC1LI2 | 4.87e-05 | 419 | 167 | 13 | int:ANXA2 |
| Interaction | CHAF1B interactions | 5.28e-05 | 158 | 167 | 8 | int:CHAF1B | |
| Interaction | PPP2CA interactions | AKAP6 ACACA MAPT PPFIA2 INTS1 MECOM CEP350 PACS1 EGFR TRIM28 SETBP1 RECQL4 PRKN ARHGEF2 | 5.31e-05 | 484 | 167 | 14 | int:PPP2CA |
| Interaction | RHOA interactions | AAMP LIMA1 IRS4 MAPT ANKRD26 RAB11FIP1 ARHGEF17 ARHGEF15 PPM1G JUP PTPN13 IGF2R DLC1 SBF1 EGFR SLC20A2 SYNE2 PALM ATP13A3 ARHGEF2 PATJ MTDH SDC2 ARHGAP21 | 5.35e-05 | 1199 | 167 | 24 | int:RHOA |
| Interaction | FER interactions | 5.77e-05 | 50 | 167 | 5 | int:FER | |
| Interaction | PSMC1 interactions | LIMA1 ACACA MAPT MECOM HUWE1 MYLK2 RGS14 EGFR TRIM28 RECQL4 PRKN MAPK6 | 5.96e-05 | 368 | 167 | 12 | int:PSMC1 |
| Interaction | RAB11A interactions | NIBAN1 SCHIP1 ZFYVE16 MAPT MUC19 ANKRD26 RAB11FIP1 JUP IGF2R EGFR SLC20A2 SYNE2 PALM ATP13A3 MTDH DYNC1LI2 WDR44 DOP1A DOP1B | 6.08e-05 | 830 | 167 | 19 | int:RAB11A |
| Interaction | RCOR1 interactions | IRS4 ACACA ZFYVE16 LRRC49 MECOM HUWE1 PTPN13 TRIM28 AHNAK RECQL4 SMARCC2 ZBTB11 USP15 ARHGAP21 | 6.61e-05 | 494 | 167 | 14 | int:RCOR1 |
| Interaction | SPTAN1 interactions | SHANK1 LIMA1 ZFYVE16 MAPT TSSC4 RGS14 JUP EGFR TRIM28 SYNE2 SMARCC2 PRKN MAPK6 AGRN | 6.90e-05 | 496 | 167 | 14 | int:SPTAN1 |
| Interaction | ARHGAP25 interactions | 6.98e-05 | 52 | 167 | 5 | int:ARHGAP25 | |
| Interaction | SIRT6 interactions | PPAN IRS4 ACACA HECTD4 HUWE1 GPATCH8 SRCAP SETDB1 ARID1B WIZ SBF1 TRIM28 SMARCC2 ARHGEF2 ZBTB11 USP15 | 7.00e-05 | 628 | 167 | 16 | int:SIRT6 |
| Interaction | H2BC12 interactions | MAPT PCLO DIDO1 HUWE1 PPM1G CEP350 AHNAK KMT2A MAPK6 ZBTB11 MTDH | 8.07e-05 | 322 | 167 | 11 | int:H2BC12 |
| Interaction | ARMCX5 interactions | 9.19e-05 | 29 | 167 | 4 | int:ARMCX5 | |
| Interaction | LAMP1 interactions | IRS4 ZFYVE16 SZT2 HUWE1 RAB11FIP1 JUP PTPN13 IGF2R SBF1 EGFR TRAPPC12 SLC20A2 C4A ATP13A3 MTDH ARHGAP21 | 9.38e-05 | 644 | 167 | 16 | int:LAMP1 |
| Interaction | H3-4 interactions | RAG1 HMGXB4 DIDO1 PABPN1L MYLK2 PPM1G SETDB1 EGFR TRIM28 AHNAK RECQL4 KMT2A KDM6A | 9.58e-05 | 448 | 167 | 13 | int:H3-4 |
| Interaction | RND3 interactions | 9.66e-05 | 273 | 167 | 10 | int:RND3 | |
| Interaction | LYN interactions | LIMA1 IRS4 ANKRD26 RAB11FIP1 PACS1 JUP PTPN13 FAM171A2 EGFR TRIM28 SLC20A2 PALM KMT2A PRKN ATP13A3 ARHGAP21 SPESP1 | 1.05e-04 | 720 | 167 | 17 | int:LYN |
| Interaction | KDM1A interactions | IRS4 ACACA ZFYVE16 MAPT LRRC49 MECOM LAMC1 HUWE1 RBBP8NL CEP350 SETDB1 JUP PTPN13 WIZ TRIM28 AHNAK RECQL4 SMARCC2 USP15 ARHGAP21 | 1.07e-04 | 941 | 167 | 20 | int:KDM1A |
| Interaction | GJA1 interactions | IRS4 ZFYVE16 ANKRD26 PPM1G RGS14 JUP PTPN13 IGF2R FAM171A2 EGFR TRIM28 SYNE2 PALM ATP13A3 ARHGAP21 | 1.07e-04 | 583 | 167 | 15 | int:GJA1 |
| Interaction | GJD3 interactions | IRS4 ZFYVE16 SYNE1 ANKRD26 JUP PTPN13 IGF2R EGFR SLC20A2 SYNE2 PALM ATP13A3 MTDH | 1.09e-04 | 454 | 167 | 13 | int:GJD3 |
| Interaction | YWHAE interactions | LIMA1 IRS4 MAPT IQSEC2 ANKRD26 SIK1 HUWE1 RAB11FIP1 MEX3C PACS1 FRMD4A JUP PTPN13 SBF1 SYNJ2 TRIM28 RECQL4 KMT2A SMARCC2 CD74 PRKN ARHGEF2 AGRN ARHGAP21 | 1.10e-04 | 1256 | 167 | 24 | int:YWHAE |
| Interaction | UBE2C interactions | 1.10e-04 | 91 | 167 | 6 | int:UBE2C | |
| Interaction | NRXN2 interactions | 1.16e-04 | 12 | 167 | 3 | int:NRXN2 | |
| Interaction | PPP2R1A interactions | IRS4 GNL3L ACACA MAPT PPFIA2 INTS1 SIK1 MEX3C CEP350 RGS14 EGFR RECQL4 PRKN ARHGEF2 MAPK6 USP15 | 1.36e-04 | 665 | 167 | 16 | int:PPP2R1A |
| Interaction | ELP1 interactions | 1.42e-04 | 182 | 167 | 8 | int:ELP1 | |
| Interaction | CREBBP interactions | MAPT HMGXB4 MECOM HUWE1 SRCAP SLC1A4 SETDB1 JUP ARID1B TRIM28 AFP KMT2A SMARCC2 KDM6A MTDH | 1.43e-04 | 599 | 167 | 15 | int:CREBBP |
| Interaction | NCAPD2 interactions | 1.50e-04 | 234 | 167 | 9 | int:NCAPD2 | |
| Interaction | RHOF interactions | IRS4 GALK1 ANKRD26 PPM1G PACS1 JUP PTPN13 IGF2R SBF1 FAM171A2 EGFR SLC20A2 PALM COBL ATP13A3 ARHGAP21 | 1.56e-04 | 673 | 167 | 16 | int:RHOF |
| Interaction | PYGM interactions | 1.66e-04 | 98 | 167 | 6 | int:PYGM | |
| Interaction | PDIA3 interactions | COL12A1 MAPT LAMC1 EGFR SYNJ2 TRIM28 SLC20A2 AHNAK RECQL4 KMT2A PRKN AGRN DYNC1LI2 | 1.74e-04 | 476 | 167 | 13 | int:PDIA3 |
| Interaction | SYNPO interactions | 2.04e-04 | 192 | 167 | 8 | int:SYNPO | |
| Interaction | KCTD13 interactions | SHANK1 LIMA1 MAPT TNC SYNE1 PPFIA2 PCLO LRRC49 IQSEC2 BCAN SPECC1L EDC4 ARHGEF17 SLC1A4 PACS1 JUP SBF1 NRXN2 TRIM28 PALM KMT2A SMARCC2 ARHGEF2 MTDH ARHGAP21 | 2.10e-04 | 1394 | 167 | 25 | int:KCTD13 |
| Interaction | TCF25 interactions | 2.18e-04 | 103 | 167 | 6 | int:TCF25 | |
| Interaction | H2BC21 interactions | RAG1 PCLO HMGXB4 DIDO1 SIK1 HUWE1 SRCAP PPM1G C2CD2L ARID1B WIZ AHNAK KMT2A SMARCC2 PRKN USP15 | 2.27e-04 | 696 | 167 | 16 | int:H2BC21 |
| Interaction | PPFIA2 interactions | 2.43e-04 | 37 | 167 | 4 | int:PPFIA2 | |
| Interaction | PC interactions | 2.43e-04 | 197 | 167 | 8 | int:PC | |
| Interaction | ATG16L1 interactions | LIMA1 PPAN ACACA MAPT CDKN2AIP KIAA0586 ANGEL1 SPECC1L GPATCH8 TSSC4 RAB11FIP1 ARHGEF17 CEP350 JUP PTPN13 IGF2R EGFR TRIM28 SMARCC2 PRKN ARHGEF2 PATJ | 2.45e-04 | 1161 | 167 | 22 | int:ATG16L1 |
| Interaction | DISC1 interactions | AKAP6 LIMA1 TCAF1 SYNE1 ANGEL1 LAMC1 SPECC1L CEP350 IGF2R PRKN AGRN MTDH | 2.50e-04 | 429 | 167 | 12 | int:DISC1 |
| Interaction | RHOJ interactions | IRS4 ZFYVE16 ANKRD26 RAB11FIP1 JUP PTPN13 IGF2R SBF1 FAM171A2 EGFR SLC20A2 PALM COBL ATP13A3 ARHGAP21 | 2.60e-04 | 633 | 167 | 15 | int:RHOJ |
| Interaction | AP2A2 interactions | 2.61e-04 | 199 | 167 | 8 | int:AP2A2 | |
| Interaction | DCTN1 interactions | MAPT SPECC1L HUWE1 CEP350 EGFR SYNJ2 TRIM28 PRKN INAVA ARHGEF2 USP15 ARHGAP21 DYNC1LI2 | 2.65e-04 | 497 | 167 | 13 | int:DCTN1 |
| Interaction | RANBP9 interactions | AAMP LIMA1 MAPT HUWE1 JUP EGFR TRIM28 RECQL4 PRKN MAPK6 USP15 MTDH | 2.72e-04 | 433 | 167 | 12 | int:RANBP9 |
| Interaction | C11orf52 interactions | IRS4 ANKRD26 JUP PTPN13 SBF1 FAM171A2 EGFR PALM ATP13A3 ARHGAP21 | 2.77e-04 | 311 | 167 | 10 | int:C11orf52 |
| Interaction | SNRNP40 interactions | CENPT ACACA CDKN2AIP GON4L GPATCH8 TSSC4 ARID1B WIZ EGFR KMT2A SMARCC2 PRKN ZBTB11 USP15 MTDH | 2.78e-04 | 637 | 167 | 15 | int:SNRNP40 |
| Interaction | RCC1 interactions | 2.79e-04 | 201 | 167 | 8 | int:RCC1 | |
| Interaction | RND2 interactions | IRS4 ANKRD26 RAB11FIP1 RGS14 JUP PTPN13 IGF2R SBF1 EGFR SLC20A2 SYNE2 MTDH | 3.14e-04 | 440 | 167 | 12 | int:RND2 |
| Interaction | H2BC4 interactions | 3.19e-04 | 259 | 167 | 9 | int:H2BC4 | |
| Interaction | DNAJC5 interactions | PIEZO1 ANKRD26 RAB11FIP1 ARHGEF15 JUP PTPN13 IGF2R SBF1 FAM171A2 EGFR PALM | 3.25e-04 | 378 | 167 | 11 | int:DNAJC5 |
| Interaction | SUPT16H interactions | AAMP ACACA MECOM PPM1G SBF1 EGFR TRIM28 RECQL4 SMARCC2 PRKN AGRN MTDH | 3.28e-04 | 442 | 167 | 12 | int:SUPT16H |
| Interaction | TIMM50 interactions | 3.38e-04 | 261 | 167 | 9 | int:TIMM50 | |
| Interaction | RHOU interactions | IRS4 ZFYVE16 PCDHGA4 ANKRD26 RAB11FIP1 JUP PTPN13 IGF2R SBF1 EGFR SLC20A2 PALM COBL | 3.39e-04 | 510 | 167 | 13 | int:RHOU |
| Interaction | MAP1S interactions | 3.43e-04 | 112 | 167 | 6 | int:MAP1S | |
| Interaction | PRSS1 interactions | 3.51e-04 | 73 | 167 | 5 | int:PRSS1 | |
| Interaction | CAV1 interactions | LIMA1 IRS4 ZFYVE16 ANKRD26 RAB11FIP1 PPM1G JUP PTPN13 IGF2R DLC1 FAM171A2 EGFR PALM COBL PRKN ARHGAP21 | 3.52e-04 | 724 | 167 | 16 | int:CAV1 |
| Interaction | GLDC interactions | LIMA1 IRS4 SPECC1L JUP RECQL4 SMARCC2 COBL PATJ MTDH ARHGAP21 | 3.57e-04 | 321 | 167 | 10 | int:GLDC |
| Interaction | FBLN5 interactions | 3.67e-04 | 159 | 167 | 7 | int:FBLN5 | |
| Interaction | HSPH1 interactions | LIMA1 ACACA MAPT HUWE1 PPM1G JUP EGFR TRIM28 RECQL4 PRKN MAPK6 WDR44 | 3.70e-04 | 448 | 167 | 12 | int:HSPH1 |
| Interaction | RHOC interactions | ANKRD26 RAB11FIP1 JUP PTPN13 IGF2R SBF1 EGFR SLC20A2 SYNE2 PALM KMT2A PRKN ATP13A3 MTDH | 3.73e-04 | 584 | 167 | 14 | int:RHOC |
| Interaction | CLDN4 interactions | 3.74e-04 | 74 | 167 | 5 | int:CLDN4 | |
| Interaction | ASH2L interactions | 3.77e-04 | 265 | 167 | 9 | int:ASH2L | |
| GeneFamily | PDZ domain containing | SHANK1 PCLO FRMPD1 PTPN13 GORASP1 AHNAK PATJ SDCBP2 ARHGAP21 | 3.45e-07 | 152 | 109 | 9 | 1220 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.14e-04 | 4 | 109 | 2 | 574 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.14e-04 | 4 | 109 | 2 | 1252 | |
| GeneFamily | Non-canonical high mobility group | 2.14e-04 | 4 | 109 | 2 | 512 | |
| GeneFamily | CD molecules|Mucins | 2.62e-04 | 21 | 109 | 3 | 648 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.92e-04 | 53 | 109 | 4 | 532 | |
| GeneFamily | Collagens|Collagen proteoglycans | 3.56e-04 | 5 | 109 | 2 | 575 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.11e-03 | 34 | 109 | 3 | 487 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.26e-03 | 9 | 109 | 2 | 1234 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.40e-03 | 50 | 109 | 3 | 1293 | |
| GeneFamily | StAR related lipid transfer domain containing | 3.59e-03 | 15 | 109 | 2 | 759 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SCHIP1 TRIM2 ZFYVE16 HMGXB4 MECOM LAMC1 SPECC1L GPATCH8 CEP350 SETDB1 PTPN13 IGF2R DLC1 EGFR SYNJ2 SLC20A2 SYNE2 ATP13A3 MAPK6 ZBTB11 SUCO USP15 DOP1B | 7.67e-09 | 856 | 169 | 23 | M4500 |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | PPAN GALK1 COL15A1 RARRES1 ZFYVE16 SYNE1 FRMD4A WIZ SBF1 DCHS1 KCNAB1 ARHGEF2 PATJ SDC2 IQCE | 1.09e-06 | 506 | 169 | 15 | M253 |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 9.16e-06 | 75 | 169 | 6 | MM1143 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | GALK1 INTS1 ARHGEF17 IGF2R SBF1 TRAPPC12 AHNAK C4B AGRN DOP1B | 1.31e-05 | 276 | 169 | 10 | M3063 |
| Coexpression | GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN | 2.31e-05 | 180 | 169 | 8 | M8906 | |
| Coexpression | GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN | 4.08e-05 | 195 | 169 | 8 | M5765 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 4.23e-05 | 196 | 169 | 8 | M5381 | |
| Coexpression | ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF | SCHIP1 TCAF1 TNC BNC1 TSC22D1 SYNJ2 ACAN PHACTR3 ARHGEF2 MAPK6 SDCBP2 ARHGAP21 DOP1A | 6.20e-05 | 550 | 169 | 13 | M2611 |
| Coexpression | YAGUE_PRETUMOR_DRUG_RESISTANCE_DN | 7.18e-05 | 13 | 169 | 3 | M2070 | |
| Coexpression | NABA_CORE_MATRISOME | 7.83e-05 | 275 | 169 | 9 | M5884 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 7.88e-05 | 68 | 169 | 5 | M1406 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | COL12A1 PPFIA2 PIEZO1 MUC16 BNC1 PTPN13 AHNAK SYNE2 KCNAB1 COBL CD74 C4B TNXB | 7.03e-06 | 369 | 166 | 13 | gudmap_kidney_adult_RenalCapsule_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | NIBAN1 SCHIP1 COL12A1 COL15A1 TNC LAMC1 ATP10B IRAG1 C4orf54 CEP350 DLC1 AHNAK COBL ATP13A3 SDCBP2 AGRN TNXB WDR44 | 3.61e-05 | 772 | 166 | 18 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | COL12A1 RARRES1 ERN1 PIEZO1 FRMPD1 MUC16 SPECC1L SLC1A4 BRWD3 MEX3C TSC22D1 STARD9 AHNAK PACC1 ATP13A3 PATJ KDM6A ARHGAP21 | 4.95e-05 | 791 | 166 | 18 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | COL12A1 COL15A1 TNC MECOM LAMC1 PTPN13 EGFR SETBP1 KIAA1755 TNXB SDC2 | 2.06e-10 | 192 | 169 | 11 | 60b1312e84f6d6448365a952469c506c00b5fe93 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | AKAP6 NIBAN1 SYNE1 IRAG1 ARHGEF17 FRMD4A SLC20A2 ACAN KCNAB1 SDC2 | 5.20e-09 | 200 | 169 | 10 | c06426f877919bdd267ea2fd7e7973c6619832ae |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | AKAP6 NIBAN1 MAPT SYNE1 IRAG1 ARHGEF17 FRMD4A ACAN KCNAB1 SDC2 | 5.20e-09 | 200 | 169 | 10 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.20e-09 | 200 | 169 | 10 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.40e-08 | 182 | 169 | 9 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-08 | 187 | 169 | 9 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.50e-08 | 188 | 169 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-08 | 191 | 169 | 9 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.89e-08 | 194 | 169 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.65e-08 | 200 | 169 | 9 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.65e-08 | 200 | 169 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 2.93e-07 | 170 | 169 | 8 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-07 | 180 | 169 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 5.35e-07 | 184 | 169 | 8 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.80e-07 | 186 | 169 | 8 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.80e-07 | 186 | 169 | 8 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-07 | 187 | 169 | 8 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-07 | 187 | 169 | 8 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 6.29e-07 | 188 | 169 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-07 | 188 | 169 | 8 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.29e-07 | 188 | 169 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-07 | 189 | 169 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-07 | 189 | 169 | 8 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-07 | 189 | 169 | 8 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-07 | 190 | 169 | 8 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.09e-07 | 191 | 169 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-07 | 191 | 169 | 8 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 7.09e-07 | 191 | 169 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 7.38e-07 | 192 | 169 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 7.38e-07 | 192 | 169 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-07 | 193 | 169 | 8 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-07 | 193 | 169 | 8 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.67e-07 | 193 | 169 | 8 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-07 | 193 | 169 | 8 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.67e-07 | 193 | 169 | 8 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.98e-07 | 194 | 169 | 8 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 8.29e-07 | 195 | 169 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 8.29e-07 | 195 | 169 | 8 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.29e-07 | 195 | 169 | 8 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.62e-07 | 196 | 169 | 8 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.62e-07 | 196 | 169 | 8 | 0b247cf981981ae61aca5de82ef687e8d783c9ef | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.95e-07 | 197 | 169 | 8 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.95e-07 | 197 | 169 | 8 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.30e-07 | 198 | 169 | 8 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-06 | 200 | 169 | 8 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.00e-06 | 200 | 169 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-06 | 200 | 169 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Nasal_Brush-Epithelial|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.00e-06 | 200 | 169 | 8 | 7911073119ee47a37b68b73fc54f063e902a5067 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-06 | 200 | 169 | 8 | 03051d2190244208905e1611019d4b8fd200bae0 | |
| ToppCell | ASK440-Epithelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.00e-06 | 200 | 169 | 8 | cb617e2a0ca82b470b473b8d5906bc8879c85718 | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.47e-06 | 158 | 169 | 7 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-06 | 164 | 169 | 7 | dcd3c3ee73900180451fad9b4de0efedbd375e1c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-06 | 164 | 169 | 7 | dd29decc6c41a580cfdf03962827ec18d432935f | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.56e-06 | 167 | 169 | 7 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.56e-06 | 167 | 169 | 7 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.70e-06 | 168 | 169 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-06 | 169 | 169 | 7 | 58098f8801ca941aeddafb47e88ab0df8b9edb57 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-06 | 169 | 169 | 7 | 1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.00e-06 | 170 | 169 | 7 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 4.00e-06 | 170 | 169 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-06 | 172 | 169 | 7 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-06 | 172 | 169 | 7 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.49e-06 | 173 | 169 | 7 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.49e-06 | 173 | 169 | 7 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-06 | 175 | 169 | 7 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-06 | 175 | 169 | 7 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.03e-06 | 176 | 169 | 7 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-06 | 179 | 169 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.83e-06 | 180 | 169 | 7 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.83e-06 | 180 | 169 | 7 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.83e-06 | 180 | 169 | 7 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 6.50e-06 | 183 | 169 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.50e-06 | 183 | 169 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 6.50e-06 | 183 | 169 | 7 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.50e-06 | 183 | 169 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.73e-06 | 184 | 169 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.73e-06 | 184 | 169 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.97e-06 | 185 | 169 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.97e-06 | 185 | 169 | 7 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 6.97e-06 | 185 | 169 | 7 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.97e-06 | 185 | 169 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.22e-06 | 186 | 169 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 7.22e-06 | 186 | 169 | 7 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-06 | 187 | 169 | 7 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.75e-06 | 188 | 169 | 7 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.75e-06 | 188 | 169 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.75e-06 | 188 | 169 | 7 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 8.02e-06 | 189 | 169 | 7 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-06 | 189 | 169 | 7 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-06 | 189 | 169 | 7 | 43e131458d8a4b120f7a5fb3d0c5650abded15f6 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-06 | 189 | 169 | 7 | d69b7a01dd4d6ad043bb6210e9ab34b49578389c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-06 | 189 | 169 | 7 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-06 | 189 | 169 | 7 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-06 | 189 | 169 | 7 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.33e-05 | 49 | 116 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | KIAA0586 SLC1A4 FAAH PACS1 SETDB1 PTPN13 SBF1 SYNJ2 ARHGEF2 PATJ KDM6A AGRN IQCE | 2.18e-09 | 196 | 166 | 13 | 7228_DN |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | GNL3L TRIM2 KIAA0586 ANKRD26 FAAH C2CD2L SETDB1 SLC20A2 KMT2A DOP1B | 1.68e-06 | 194 | 166 | 10 | 1670_DN |
| Drug | Dirithromycin [62013-04-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.68e-06 | 194 | 166 | 10 | 2863_UP | |
| Drug | quercetin dihydrate; Up 200; 1uM; MCF7; HG-U133A | WRAP53 ARHGEF17 C2CD2L IGF2R WIZ SBF1 SYNJ2 TRAPPC12 COBL AGRN | 1.84e-06 | 196 | 166 | 10 | 283_UP |
| Drug | phenylarsonic acid | 1.85e-06 | 13 | 166 | 4 | CID000007365 | |
| Drug | Bufexamac [2438-72-4]; Down 200; 18uM; MCF7; HT_HG-U133A | TRIM2 MAPT KIAA0586 DIDO1 PTPN13 EGFR HMGXB3 PATJ SDC2 DOP1B | 2.02e-06 | 198 | 166 | 10 | 5515_DN |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; PC3; HT_HG-U133A | IRS4 TRIM2 FRMPD1 ARHGEF17 FAAH C2CD2L BNC1 DLC1 KCNAB1 CD74 | 2.11e-06 | 199 | 166 | 10 | 4494_UP |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.29e-06 | 177 | 166 | 9 | 985_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.11e-05 | 190 | 166 | 9 | 6943_DN | |
| Drug | Apigenin [520-36-5]; Up 200; 14.8uM; PC3; HT_HG-U133A | 1.43e-05 | 196 | 166 | 9 | 4578_UP | |
| Drug | Timolol maleate salt [26921-17-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.43e-05 | 196 | 166 | 9 | 5280_DN | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A | 1.43e-05 | 196 | 166 | 9 | 4291_UP | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.43e-05 | 196 | 166 | 9 | 6435_UP | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 2285_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; HL60; HG-U133A | C14orf93 ACACA SRCAP ARHGEF15 TRAPPC12 ACAN KDM6A WDR44 DOP1A | 1.49e-05 | 197 | 166 | 9 | 1763_UP |
| Drug | chlorpropamide; Down 200; 100uM; MCF7; HG-U133A | 1.55e-05 | 198 | 166 | 9 | 144_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HG-U133A | 1.55e-05 | 198 | 166 | 9 | 1917_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 5295_UP | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 6841_DN | |
| Drug | genistein; Down 200; 1uM; MCF7; HG-U133A | 1.61e-05 | 199 | 166 | 9 | 267_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.61e-05 | 199 | 166 | 9 | 6321_DN | |
| Drug | Butacaine [149-16-6]; Up 200; 13uM; PC3; HT_HG-U133A | AKAP6 C14orf93 SRCAP ARHGEF17 PACS1 DLC1 AHNAK MCM3AP KCNAB1 | 1.61e-05 | 199 | 166 | 9 | 5748_UP |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.68e-05 | 200 | 166 | 9 | 3056_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 4.28e-05 | 174 | 166 | 8 | 7136_UP | |
| Drug | Pyrvinium pamoate [3546-41-6]; Up 200; 3.4uM; PC3; HT_HG-U133A | 6.12e-05 | 183 | 166 | 8 | 6339_UP | |
| Drug | Chlorpyrifos | LIMA1 TCAF1 ACACA PCLO SPECC1L HUWE1 EDC4 CHRM1 SLC1A4 FAAH MEX3C IGF2R MYLK3 EGFR AFP KMT2A PRKN AGRN MTDH | 7.72e-05 | 960 | 166 | 19 | ctd:D004390 |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 8.25e-05 | 191 | 166 | 8 | 3890_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 8.56e-05 | 192 | 166 | 8 | 1634_UP | |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 8.88e-05 | 193 | 166 | 8 | 2764_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 8.88e-05 | 193 | 166 | 8 | 4202_DN | |
| Drug | Piroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A | 9.20e-05 | 194 | 166 | 8 | 1405_DN | |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 7164_UP | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 3525_DN | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 7239_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 7225_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 6761_UP | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 3849_DN | |
| Drug | Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 3534_DN | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; PC3; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 4600_UP | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 5793_UP | |
| Drug | Ethosuximide [77-67-8]; Down 200; 28.4uM; MCF7; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 2280_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 4539_DN | |
| Drug | Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 3878_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 3742_UP | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 1696_DN | |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 5807_UP | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 4181_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 3447_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; PC3; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 3724_UP | |
| Drug | Stachydrine hydrochloride; Up 200; 22.2uM; HL60; HG-U133A | 1.02e-04 | 197 | 166 | 8 | 1751_UP | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 7342_DN | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 3390_UP | |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; PC3; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 7491_UP | |
| Drug | Tamoxifen citrate [54965-24-1]; Up 200; 7uM; HL60; HG-U133A | 1.02e-04 | 197 | 166 | 8 | 1366_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 3769_DN | |
| Drug | rofecoxib; Down 200; 10uM; PC3; HG-U133A | 1.02e-04 | 197 | 166 | 8 | 463_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 2307_UP | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 5334_UP | |
| Drug | Pentylenetetrazole [54-95-5]; Up 200; 29uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 2255_UP | |
| Drug | Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 5876_UP | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 6657_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 6907_UP | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; HL60; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 3135_UP | |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 3576_DN | |
| Drug | Zaprinast [37762-06-4]; Up 200; 14.8uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 6749_UP | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 6505_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 7035_UP | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; HL60; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 1862_DN | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 5003_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; HL60; HG-U133A | 1.10e-04 | 199 | 166 | 8 | 1552_UP | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 2866_UP | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; HL60; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 2347_UP | |
| Drug | tolbutamide; Down 200; 100uM; MCF7; HG-U133A | 1.10e-04 | 199 | 166 | 8 | 142_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 5787_DN | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 2882_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 2243_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 1521_UP | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 7233_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 6923_DN | |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; PC3; HG-U133A | 1.10e-04 | 199 | 166 | 8 | 1893_UP | |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; PC3; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 5756_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 7217_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 4228_DN | |
| Drug | Dibucaine [85-79-0]; Up 200; 11.6uM; PC3; HG-U133A | 1.10e-04 | 199 | 166 | 8 | 1889_UP | |
| Drug | Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; PC3; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 4065_UP | |
| Drug | Minocycline hydrochloride [13614-98-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.14e-04 | 200 | 166 | 8 | 7436_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.14e-04 | 200 | 166 | 8 | 3405_DN | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.45e-04 | 155 | 166 | 7 | 6817_DN | |
| Drug | bromide | 1.56e-04 | 267 | 166 | 9 | CID000000259 | |
| Drug | 2-aminothiophenol | 1.58e-04 | 3 | 166 | 2 | ctd:C005464 | |
| Drug | chondroitin sulfate | COL12A1 TNC KIAA0586 LAMC1 BCAN PAGR1 ACAN C4A AGRN TNXB SDC2 | 2.34e-04 | 413 | 166 | 11 | CID000024766 |
| Drug | Demecolcine | LIMA1 TCAF1 GNL3L ZFYVE16 HECTD4 MUC19 GON4L DIDO1 RAB11FIP1 ZBTB44 TSC22D1 SETD5 AHNAK SETBP1 SYNE2 SMARCC2 WDR44 | 2.42e-04 | 878 | 166 | 17 | ctd:D003703 |
| Drug | Cyclosporin A [59865-13-3]; Up 200; 3.4uM; PC3; HT_HG-U133A | 2.75e-04 | 172 | 166 | 7 | 4586_UP | |
| Drug | Ge-68 | 3.14e-04 | 4 | 166 | 2 | CID000133044 | |
| Drug | 3-ethylpyridine | 3.14e-04 | 4 | 166 | 2 | CID000010823 | |
| Drug | 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione | 3.22e-04 | 45 | 166 | 4 | ctd:C020175 | |
| Drug | bepridil | 3.29e-04 | 126 | 166 | 6 | CID000002351 | |
| Drug | HepI | 3.96e-04 | 20 | 166 | 3 | CID003036968 | |
| Drug | NSC3077 | 3.96e-04 | 20 | 166 | 3 | CID000025889 | |
| Drug | AG-1478; Up 200; 31.6uM; MCF7; HT_HG-U133A_EA | 4.00e-04 | 183 | 166 | 7 | 1141_UP | |
| Disease | Colorectal Carcinoma | AKAP6 SHANK1 IRS4 ABCA4 ACACA SYNE1 LAMC1 DLC1 MYLK3 EGFR TRIM28 MCM3AP SETBP1 DCHS1 SDCBP2 KDM6A MTDH | 5.11e-07 | 702 | 166 | 17 | C0009402 |
| Disease | Neurodevelopmental Disorders | 1.47e-05 | 93 | 166 | 6 | C1535926 | |
| Disease | Malignant neoplasm of breast | AKAP6 ABCA4 SYNE1 FRMPD1 MECOM FAAH ARID1B EGFR SYNJ2 TRAPPC12 AFP SETBP1 SYNE2 CD74 PACC1 MTDH MAGEC2 DOP1A | 3.76e-05 | 1074 | 166 | 18 | C0006142 |
| Disease | Intellectual Disability | AKAP6 SYNE1 GON4L SPECC1L SLC1A4 BRWD3 PACS1 NRXN2 SETBP1 SMARCC2 ZBTB11 | 4.91e-05 | 447 | 166 | 11 | C3714756 |
| Disease | cortical thickness | AKAP6 COL12A1 ABCA4 MAPT LRRC49 ESPNL MECOM LAMC1 IRAG1 BNC1 ARID1B DLC1 EGFR SETD5 KIAA1755 KMT2A USP15 ARHGAP21 | 5.95e-05 | 1113 | 166 | 18 | EFO_0004840 |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 6.25e-05 | 74 | 166 | 5 | DOID:3748 (is_marker_for) | |
| Disease | Down syndrome (implicated_via_orthology) | 7.57e-05 | 15 | 166 | 3 | DOID:14250 (implicated_via_orthology) | |
| Disease | Myeloid Leukemia | 1.34e-04 | 18 | 166 | 3 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.34e-04 | 18 | 166 | 3 | C0023466 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.87e-04 | 4 | 166 | 2 | cv:CN293514 | |
| Disease | monoclonal gammopathy | 2.28e-04 | 53 | 166 | 4 | EFO_0000203 | |
| Disease | breast cancer, COVID-19 | 2.49e-04 | 22 | 166 | 3 | MONDO_0007254, MONDO_0100096 | |
| Disease | prostate cancer (is_marker_for) | 2.62e-04 | 156 | 166 | 6 | DOID:10283 (is_marker_for) | |
| Disease | ovarian cancer (is_implicated_in) | 2.82e-04 | 56 | 166 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | Carcinoma of lung | 2.85e-04 | 23 | 166 | 3 | C0684249 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 3.11e-04 | 5 | 166 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 3.11e-04 | 5 | 166 | 2 | C0410190 | |
| Disease | temporal lobe epilepsy (is_implicated_in) | 3.11e-04 | 5 | 166 | 2 | DOID:3328 (is_implicated_in) | |
| Disease | lipoprotein A measurement | 4.38e-04 | 112 | 166 | 5 | EFO_0006925 | |
| Disease | Emery-Dreifuss muscular dystrophy | 4.65e-04 | 6 | 166 | 2 | cv:C0410189 | |
| Disease | cerebrospinal fluid biomarker measurement, monocyte chemotactic protein 1 measurement | 4.65e-04 | 6 | 166 | 2 | EFO_0006794, EFO_0010596 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.65e-04 | 6 | 166 | 2 | C0410189 | |
| Disease | Drug habituation | 4.95e-04 | 115 | 166 | 5 | C0013170 | |
| Disease | Drug abuse | 4.95e-04 | 115 | 166 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.95e-04 | 115 | 166 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 4.95e-04 | 115 | 166 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 4.95e-04 | 115 | 166 | 5 | C0013222 | |
| Disease | Drug Dependence | 4.95e-04 | 115 | 166 | 5 | C1510472 | |
| Disease | Substance Dependence | 4.95e-04 | 115 | 166 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 4.95e-04 | 115 | 166 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.95e-04 | 115 | 166 | 5 | C0029231 | |
| Disease | Substance abuse problem | 5.15e-04 | 116 | 166 | 5 | C0740858 | |
| Disease | colorectal cancer (is_implicated_in) | 6.24e-04 | 121 | 166 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | age at diagnosis, osteoarthritis | 6.49e-04 | 7 | 166 | 2 | EFO_0004918, MONDO_0005178 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 6.49e-04 | 7 | 166 | 2 | C0751337 | |
| Disease | lymphatic vessel endothelial hyaluronic acid receptor 1 measurement | 8.61e-04 | 8 | 166 | 2 | EFO_0020539 | |
| Disease | Cornelia De Lange Syndrome | 8.61e-04 | 8 | 166 | 2 | C0270972 | |
| Disease | Lymphoid leukemia | 8.61e-04 | 8 | 166 | 2 | C0023448 | |
| Disease | ovarian neoplasm | 9.88e-04 | 134 | 166 | 5 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 1.09e-03 | 137 | 166 | 5 | C1140680 | |
| Disease | amnestic disorder (implicated_via_orthology) | 1.10e-03 | 9 | 166 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.10e-03 | 9 | 166 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Cancer of Nasopharynx | 1.10e-03 | 9 | 166 | 2 | C0238301 | |
| Disease | Nasopharyngeal Neoplasms | 1.10e-03 | 9 | 166 | 2 | C0027439 | |
| Disease | Epilepsy, Cryptogenic | 1.20e-03 | 82 | 166 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.20e-03 | 82 | 166 | 4 | C0751111 | |
| Disease | Aura | 1.20e-03 | 82 | 166 | 4 | C0236018 | |
| Disease | platelet component distribution width | SYNE1 MECOM C4orf54 ARHGEF15 DLC1 EGFR SYNJ2 PHACTR3 ATP13A3 USP15 TNXB IQCE | 1.22e-03 | 755 | 166 | 12 | EFO_0007984 |
| Disease | tenascin measurement | 1.37e-03 | 10 | 166 | 2 | EFO_0008296 | |
| Disease | late-onset Alzheimers disease | 1.38e-03 | 292 | 166 | 7 | EFO_1001870 | |
| Disease | obesity (implicated_via_orthology) | 1.41e-03 | 215 | 166 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.54e-03 | 148 | 166 | 5 | C0279702 | |
| Disease | nasopharyngeal neoplasm | 1.68e-03 | 151 | 166 | 5 | EFO_0004252 | |
| Disease | high grade glioma (is_marker_for) | 1.71e-03 | 42 | 166 | 3 | DOID:3070 (is_marker_for) | |
| Disease | hematocrit | ACACA MAPT PIEZO1 HECTD4 MECOM RBBP8NL IRAG1 ARHGEF15 FRMD4A RGS14 ARID1B SLC20A2 MAMSTR ARHGAP21 | 1.79e-03 | 1011 | 166 | 14 | EFO_0004348 |
| Disease | Memory Loss | 1.83e-03 | 43 | 166 | 3 | C0751295 | |
| Disease | Age-Related Memory Disorders | 1.83e-03 | 43 | 166 | 3 | C0751292 | |
| Disease | Memory Disorder, Spatial | 1.83e-03 | 43 | 166 | 3 | C0751294 | |
| Disease | Memory Disorder, Semantic | 1.83e-03 | 43 | 166 | 3 | C0751293 | |
| Disease | Memory Disorders | 1.83e-03 | 43 | 166 | 3 | C0025261 | |
| Disease | unipolar depression, bipolar disorder | 1.93e-03 | 156 | 166 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Memory impairment | 1.96e-03 | 44 | 166 | 3 | C0233794 | |
| Disease | hair color | 1.97e-03 | 311 | 166 | 7 | EFO_0003924 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.00e-03 | 12 | 166 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 2.00e-03 | 12 | 166 | 2 | C3160718 | |
| Disease | protein FAM3D measurement | 2.00e-03 | 12 | 166 | 2 | EFO_0021869 | |
| Disease | serum gamma-glutamyl transferase measurement | AAMP OBP2B HECTD4 GON4L SPECC1L ARHGEF15 PPM1G SYNJ2 AHNAK RP1L1 KMT2A ARHGEF2 ARHGAP21 | 2.06e-03 | 914 | 166 | 13 | EFO_0004532 |
| Disease | Squamous cell carcinoma of esophagus | 2.07e-03 | 95 | 166 | 4 | C0279626 | |
| Disease | Coffin-Siris syndrome | 2.36e-03 | 13 | 166 | 2 | C0265338 | |
| Disease | Liver carcinoma | 2.39e-03 | 507 | 166 | 9 | C2239176 | |
| Disease | corpus callosum volume measurement | 2.49e-03 | 100 | 166 | 4 | EFO_0010299 | |
| Disease | hair colour measurement | ZFYVE16 PIEZO1 SIK1 PABPN1L PPM1G BNC1 AHNAK SETBP1 SYNE2 SLC22A31 | 2.63e-03 | 615 | 166 | 10 | EFO_0007822 |
| Disease | Prostatic Neoplasms | 2.66e-03 | 616 | 166 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.66e-03 | 616 | 166 | 10 | C0376358 | |
| Disease | Neoplasm of lung | 2.74e-03 | 14 | 166 | 2 | cv:C0024121 | |
| Disease | Lung cancer | 2.74e-03 | 14 | 166 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 2.74e-03 | 14 | 166 | 2 | 211980 | |
| Disease | high grade glioma (biomarker_via_orthology) | 3.15e-03 | 15 | 166 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 3.15e-03 | 15 | 166 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | complement C4 measurement | 3.16e-03 | 52 | 166 | 3 | EFO_0004984 | |
| Disease | Epilepsy | 3.40e-03 | 109 | 166 | 4 | C0014544 | |
| Disease | Breast Carcinoma | 3.54e-03 | 538 | 166 | 9 | C0678222 | |
| Disease | phosphatidylcholine 38:3 measurement | 3.58e-03 | 16 | 166 | 2 | EFO_0010385 | |
| Disease | Glioblastoma Multiforme | 3.63e-03 | 111 | 166 | 4 | C1621958 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 3.67e-03 | 181 | 166 | 5 | DOID:684 (is_implicated_in) | |
| Disease | coffee consumption measurement | 3.76e-03 | 182 | 166 | 5 | EFO_0006781 | |
| Disease | breast cancer (is_marker_for) | 4.03e-03 | 185 | 166 | 5 | DOID:1612 (is_marker_for) | |
| Disease | blood urea nitrogen measurement | 4.20e-03 | 452 | 166 | 8 | EFO_0004741 | |
| Disease | irritable bowel syndrome symptom measurement | 4.30e-03 | 58 | 166 | 3 | EFO_0021536 | |
| Disease | systemic lupus erythematosus, COVID-19 | 4.30e-03 | 58 | 166 | 3 | MONDO_0007915, MONDO_0100096 | |
| Disease | sweet liking measurement | 4.54e-03 | 18 | 166 | 2 | EFO_0010156 | |
| Disease | diastolic blood pressure, systolic blood pressure | OBP2B LRRC49 MECOM RBBP8NL CEP350 ZBTB44 ARID1B DLC1 ACAN SETBP1 | 4.79e-03 | 670 | 166 | 10 | EFO_0006335, EFO_0006336 |
| Disease | Varicose veins | 4.81e-03 | 193 | 166 | 5 | HP_0002619 | |
| Disease | Colorectal Neoplasms | 4.93e-03 | 277 | 166 | 6 | C0009404 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.02e-03 | 195 | 166 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | atrial fibrillation | 5.18e-03 | 371 | 166 | 7 | EFO_0000275 | |
| Disease | non-lobar intracerebral hemorrhage | 5.42e-03 | 63 | 166 | 3 | EFO_0010178 | |
| Disease | acne | 5.52e-03 | 125 | 166 | 4 | EFO_0003894 | |
| Disease | Osteoarthritis of hip | 5.59e-03 | 20 | 166 | 2 | C0029410 | |
| Disease | citrulline measurement | 5.59e-03 | 20 | 166 | 2 | EFO_0009777 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEGTAAGQLLSPETV | 116 | A6NDY0 | |
| PGTNDGSTEAAITLL | 1976 | A6H8Y1 | |
| GLSGPTDETLDSIAL | 156 | Q8NAG6 | |
| TASDPLDTLGSEGAL | 981 | P0C0L5 | |
| DLGLSSFGISDTPLE | 1256 | P78363 | |
| ETVASQPSLGEGEES | 301 | Q13685 | |
| GGISLSELEASVASP | 896 | Q9H7F0 | |
| SDPDTGSEEEGSSRL | 941 | Q92974 | |
| GTLSVDGETPVLGES | 1466 | O00468 | |
| NSGPLSEGTILDLST | 846 | Q01954 | |
| TSSVEGSAPGSVEDL | 311 | Q69YQ0 | |
| GSAPGSVEDLLSQDE | 316 | Q69YQ0 | |
| PASVGSDTLSDLGIS | 51 | Q13085 | |
| TEIVDLDSDGPGTSS | 1271 | Q6RI45 | |
| SVGAPDLSLEASEGS | 5386 | Q09666 | |
| IGPGDSNDSSELQLT | 456 | Q5JWR5 | |
| LDLLSEDGIQTGDSP | 301 | O94989 | |
| LSGSIDDLPTGTEAT | 751 | Q8NFD5 | |
| LVEESSGELEVPGSS | 136 | Q6P1W5 | |
| LESGSIASPLGSTDE | 1671 | Q9UPS8 | |
| APSDTDLGESLGANV | 641 | O94823 | |
| GDPLGIEDSLESQDS | 1026 | P15918 | |
| LEGTPSSASEGDEDL | 56 | O75781 | |
| APLSEEGEVTSGLQA | 16 | Q9BTK6 | |
| SEGALSPDGTVLATA | 301 | Q6P2E9 | |
| GEPALDTGDDSLSAV | 6 | Q6IPM2 | |
| LLTVTASDPDEGING | 261 | Q9Y5G5 | |
| DLDDVSTPSGSDLET | 581 | Q03112 | |
| TDGEGALSEPSATVT | 186 | P04217 | |
| SSSSELLLTGPGAEE | 566 | Q96PE2 | |
| LSGPESSLTDEGIGA | 636 | Q96PE2 | |
| DGSTGVELAPRSADS | 601 | Q9Y5G9 | |
| ESEETGSSEGAPSLL | 581 | Q96GW7 | |
| ATSLEASEGGLPTLS | 1226 | Q8WXI7 | |
| VSSGDPSGLFELDES | 2641 | Q96JQ0 | |
| TADPEGTETALAGDT | 401 | Q6ZVH7 | |
| STSSSLILGGPEEEE | 56 | Q9UBF1 | |
| LDDLEIGPGQLSSST | 231 | Q9UHB6 | |
| EGEEESSAGSLPLVS | 2021 | Q8N201 | |
| TSGALEEIAGTKETP | 301 | Q5JYT7 | |
| KTSTELAEEPATGGI | 261 | Q8IYT1 | |
| NEGVSSVLLGSSTPE | 366 | Q14722 | |
| SEDSGIGLSASSPEL | 586 | Q9Y3R5 | |
| SVEGDAPGSDLSTAV | 246 | Q5JU85 | |
| TAAEESEEAPLTGGL | 181 | O14990 | |
| ESTDSLGGLSPSEVT | 421 | O60318 | |
| SGESEEASPSLTAEE | 31 | O15550 | |
| SEIEVPLLGSSGSSE | 286 | Q9NXV6 | |
| LTSGSDEENVALPLG | 201 | O43237 | |
| EVTLGTTDNDSPGAD | 451 | Q12766 | |
| IVLTGDATSPEGETD | 81 | Q9Y6F6 | |
| GLSLEADITGNLDSP | 171 | Q8N7N1 | |
| PGSDIASGSDVLSDV | 141 | Q6PEV8 | |
| DEDPQDGGSLASTLS | 361 | Q9UKJ3 | |
| SSDGISSSLGEIPSL | 1366 | Q9Y6V0 | |
| PSGSQLTDDVGSLTE | 86 | Q16659 | |
| AEATGTIGPSTEGLE | 3081 | Q7Z5P9 | |
| LSGLSPFLGETDAET | 706 | Q32MK0 | |
| LSGLSPFLGDDDTET | 476 | Q9H1R3 | |
| GLVSLLTTSEGADEP | 71 | P51570 | |
| GEGPSVLLSAETTAT | 1341 | Q9P2S2 | |
| QIDGSTLSAFPEETG | 376 | Q8IUZ0 | |
| GLEPILVESDSSSGG | 286 | Q9UGU5 | |
| SLGSLGEPLDNAETA | 3126 | Q9Y4D8 | |
| PLGDTASNLGSAVDE | 651 | Q7Z6Z7 | |
| PGVSGEDSSLLLATQ | 91 | P14923 | |
| AEEEPASTEGLDTGT | 411 | Q9BQQ3 | |
| LVEDSPSTAGDGDDS | 756 | Q6VY07 | |
| GDLSGLPSGEVLETT | 971 | P16112 | |
| DISGLPSGEVVETSA | 1486 | P16112 | |
| VSELPSGEGLETSAS | 1506 | P16112 | |
| ETSASEVGTDLSGLP | 1556 | P16112 | |
| LETSASGAEDLSGLP | 1576 | P16112 | |
| GITDLSGETSGVPDL | 1781 | P16112 | |
| SVASPSSGGEDEDLD | 226 | A8K0S8 | |
| EGPVGSTLSLSLDSD | 1716 | O95248 | |
| GILPGLDSESASSSI | 41 | Q9H813 | |
| AAGTTDSEGVATLPL | 71 | A8MVW0 | |
| GLSEEDIFTPLQTGS | 151 | Q9NPH6 | |
| LSLSSPGSTEDEDTG | 521 | Q8NC74 | |
| TGEATENSPILDGSE | 1016 | Q9P2Q2 | |
| SDPTGALTEDSIDDT | 1071 | P00533 | |
| RPSVDDIESETGSTG | 611 | O14523 | |
| SGEGEPLTGDATTEL | 981 | Q99715 | |
| PGDTAQDGELLDTSG | 501 | O75460 | |
| GSPGLAESIDSDSQE | 631 | Q5SYB0 | |
| PGGEALASSESETEQ | 111 | Q9UMQ3 | |
| LDSALEESGPGSTGE | 261 | Q9H972 | |
| LSTSSGVSGEDEVEP | 311 | Q96BT3 | |
| SAQGSESPLLEDLGL | 1186 | O75128 | |
| EGLSGISPLSSDEVT | 976 | Q96RY5 | |
| ISPLSSDEVTGAISG | 981 | Q96RY5 | |
| LDTGAPSEELSSAGE | 1356 | Q3T8J9 | |
| GSSIDSVSEGPLLSE | 976 | Q5VT06 | |
| SVSEGPLLSEGSLSE | 981 | Q5VT06 | |
| PLLSEGSLSEEEGDQ | 986 | Q5VT06 | |
| VGSEASDTVEGVLPS | 201 | Q9BTC0 | |
| GGLEEPDALDDSLTS | 21 | Q92949 | |
| ESLTSSEGEEPGSEV | 286 | P11229 | |
| LTDSGSLDSTIPGIE | 211 | Q86UE4 | |
| SSGPGSAALTLEEEL | 281 | Q6ZN01 | |
| SPESSSSELLNLGEG | 2866 | Q03164 | |
| TDEFSDISPLTGGNV | 206 | P11047 | |
| DSTLGLSLNEGVPAE | 151 | O00519 | |
| CSESLELEDPSSGLG | 271 | P04233 | |
| GSDETPGDITSLTEE | 411 | D6RIA3 | |
| GEEATVGPSSEDSLT | 446 | P39059 | |
| DSLDEARSSGSEGTP | 426 | Q6NUJ5 | |
| GSGADEDVESPELTT | 56 | P34741 | |
| GPGDSSLEENSLATE | 296 | A6NKX4 | |
| DDSTIPLTGAAGETL | 281 | Q08357 | |
| EVSDTDSGIILQSGP | 91 | Q3KP66 | |
| LIQGDPGASSEEETL | 436 | Q9C0B2 | |
| TASDPLDTLGSEGAL | 981 | P0C0L4 | |
| LTAIEKPTGDEQSSG | 71 | P02771 | |
| SVSLEPESLGLGSAN | 801 | O75334 | |
| ESSSGLPGVDETLSQ | 441 | Q12923 | |
| SGSGEDDLVTAPANI | 1656 | Q12923 | |
| PLSATGSNAIEEEGD | 1001 | O14654 | |
| ASSGEEADAGSLLPT | 186 | Q96KR7 | |
| DVSIDLTPLAQSGGS | 336 | P11717 | |
| DLSPSTGIVDDSTGE | 101 | Q5T011 | |
| LGPAGLDSASLSDVD | 1521 | Q5T011 | |
| SLSSDGAVSPVGELA | 731 | Q6WKZ4 | |
| GSLSEEEANGPELGS | 111 | Q9BUR4 | |
| DLSSSVLPGDSVGLA | 106 | O60260 | |
| LLSPVTEESGEEGTN | 5856 | Q8NF91 | |
| ADTLDSSDAQGGLEP | 4211 | Q8WXH0 | |
| VSDSELGGDDLSDVP | 1031 | O15056 | |
| VGGIDTSIEPNLTSD | 316 | Q9Y4C2 | |
| GSDTAGRSESSDPLE | 101 | Q8NHL6 | |
| SSSPGGSLDLVSALE | 61 | P0DPB3 | |
| DLGSEESQLLIPGES | 211 | O94761 | |
| LATGESDELLGDTDP | 441 | Q9NVN8 | |
| EEPGSDSGTTAVVAL | 321 | O15355 | |
| GDTLPSVGSEDLAVD | 481 | Q5U5Q3 | |
| LVTPTEAGSLDSSGE | 656 | Q9C0A6 | |
| EAGSLDSSGENRPLT | 661 | Q9C0A6 | |
| SSDLSGLEVPQEGLS | 366 | A0A0B4J2F2 | |
| SSDLSGLEVPQEGLS | 366 | P57059 | |
| GISTESEDVPQLSGE | 191 | Q6UW49 | |
| LGVAESESSGAPIDL | 896 | O95785 | |
| TTPLVDGEDESSSGA | 961 | Q15714 | |
| ETEDVGLTSGVSLAP | 2511 | Q9P2P6 | |
| DSAEGTTLTVLPEGE | 2626 | Q6ZRS2 | |
| PDLESGSESGADTIS | 391 | Q96QB1 | |
| ESSGIAGTTSDEPER | 736 | Q8TAQ2 | |
| SLLQIPEGDSTAVSG | 66 | Q9H190 | |
| DVLSIDSGDAGSRTP | 131 | Q15047 | |
| DSGETPLTLAAQTEG | 211 | Q9Y566 | |
| SSLGESIESGPLSDI | 706 | Q13023 | |
| EEGLSQVLSTASEGP | 66 | Q9UNK9 | |
| DEVSSVSVGPLGSLD | 696 | P98169 | |
| SSEGTTTSLPTELGD | 346 | O95625 | |
| GSQLDVSEPGTLSSV | 876 | Q5TCY1 | |
| RTPSDLESGKGSSDE | 96 | Q68D42 | |
| EDTAGLPGTCSSELE | 671 | Q9BZQ8 | |
| EPALSTALGSQLGEE | 1636 | Q8IWN7 | |
| LISDSPNSEGDAGDL | 71 | Q8WVT3 | |
| LATGAGLSESEAEPD | 231 | Q9NQ55 | |
| QSGTEPISSEEDGSV | 1346 | Q8NI35 | |
| DSELSSSEGLEPGSA | 286 | Q9BQI7 | |
| QTLQSSDLGLEDSGP | 146 | P43007 | |
| GELTVTGSSPDSLSL | 1376 | P22105 | |
| GELTVTGSSPDSLSL | 2526 | P22105 | |
| GELTVTGSSPDSLSL | 2956 | P22105 | |
| LSAEASTGETPNLGE | 1156 | P24821 | |
| LISPQSSSIGSVDEG | 331 | Q8NCP5 | |
| SVDEGVSEGLPTLQS | 341 | Q8NCP5 | |
| LSDSDSDLSLPGGAE | 31 | Q9Y5U2 | |
| SDLSLPGGAEVEALS | 36 | Q9Y5U2 | |
| GGDVLEPVSSDSLST | 186 | Q5JSH3 | |
| ASAATGIPLESDEDS | 951 | Q9Y4E8 | |
| TTAEEAGIGDTPSLE | 101 | P10636 | |
| VLAVSDGELSSTTGP | 16 | O43566 | |
| EEASPSTVTLLGSGE | 586 | Q9UBS9 | |
| GEPSLQSDGSEVLLS | 586 | Q6UXZ4 | |
| SPEDIVTAQIEGSSG | 2261 | Q92508 | |
| TAELSTPDGSVADGE | 366 | Q9C040 | |
| STSDLSRGEIGDPQT | 1861 | Q5T5U3 | |
| SEETIPSDSGIGTDN | 861 | Q9Y6X0 | |
| LQTPEEASGTEEGSA | 271 | P49788 | |
| PLTSDIVEGTSSGAL | 961 | Q9BVV6 | |
| NEGLPTSGSFTLDDD | 956 | Q7Z3T8 | |
| DSTFSLDQPGGTLDL | 726 | Q13263 | |
| TGLPATLTTADLGEE | 2926 | Q9UKN1 | |
| TSAEESSADVPLLGE | 836 | Q9NR99 |